TNYA
Tenaya Therapeutics Inc
NASDAQ: TNYA · HEALTHCARE · BIOTECHNOLOGY
$0.69
+4.66% today
Updated 2026-04-30
Market cap
$145.87M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.59
Dividend yield
—
52W range
$0 – $2
Volume
4.3M
Tenaya Therapeutics Inc (TNYA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — |
| Cost of revenue | $1.99M | $2.48M | $4.03M | $8.71M | $8.69M | $8.47M | $8.44M |
| Gross profit | $-1.99M | $-2.48M | $-4.03M | $-8.71M | $-8.69M | $-8.47M | $-8.44M |
| Gross margin | — | — | — | — | — | — | — |
| R&D | $23.15M | $31.10M | $54.39M | $94.54M | $98.04M | $86.74M | $68.61M |
| SG&A | $4.56M | $7.81M | $18.41M | $31.08M | $33.16M | $29.21M | $24.72M |
| Operating income | $-27.71M | $-38.91M | $-72.81M | $-125.62M | $-131.19M | $-115.95M | $-93.33M |
| Operating margin | — | — | — | — | — | — | — |
| EBITDA | $-25.72M | $-35.91M | $-69.84M | $-119.15M | $-115.40M | $-102.66M | $-84.89M |
| EBITDA margin | — | — | — | — | — | — | — |
| EBIT | $-27.71M | $-38.40M | $-72.81M | $-125.62M | $-124.08M | $-111.13M | $-93.33M |
| Interest expense | $0.00 | $0.00 | $72.73M | $1956.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-25.78M | $-38.40M | $-69.65M | $-123.66M | $-124.08M | $-111.13M | $-90.60M |
| Net income growth (YoY) | — | -48.9% | -81.4% | -77.5% | -0.3% | +10.4% | +18.5% |
| Profit margin | — | — | — | — | — | — | — |